Lanosterol 14-alpha demethylase mRNA (CYP51 mRNA)

Lanosterol 14-alpha demethylase (CYP51) mRNA is the messenger RNA transcript that encodes the CYP51 enzyme, a critical member of the cytochrome P450 superfamily involved in sterol biosynthesis (NCBI Gene, 2024). In fungi, the CYP51 enzyme (often encoded by ERG11 or CYP51 genes) catalyzes the demethylation of lanosterol to produce ergosterol, an essential component of the fungal cell membrane (UniProt, 2024). While the CYP51 protein is the primary target for azole antifungals, the mRNA transcript is an emerging target for RNA-based therapeutics designed to overcome drug resistance. Strategies such as RNA interference (RNAi) and antisense oligonucleotides (ASOs) target the CYP51 mRNA for degradation, thereby preventing the synthesis of the enzyme and disrupting fungal membrane integrity (Nishimoto et al., 2019). In agricultural biotechnology, spray-induced gene silencing (SIGS) utilizing double-stranded RNA (dsRNA) specific to CYP51 mRNA is being explored as a method to control fungal pathogens like Fusarium graminearum (Koch et al., 2013). The primary therapeutic challenge for this target is ensuring high specificity to avoid silencing the host's endogenous CYP51 mRNA, which is vital for cholesterol or phytosterol synthesis.

Other names

Cytochrome P450 family 51 subfamily A member 1 mRNACYP51A1 mRNALdm mRNAErg11 mRNASterol 14-alpha-demethylase mRNA

RNA interference (RNAi) or antisense-mediated degradation of the transcript, leading to reduced translation of the lanosterol 14-alpha demethylase enzyme.